-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Xetra FrankfurtISIN US717081ER06-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009Symbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10Symbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61Symbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06Symbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082Symbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31Symbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88Symbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23Symbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02Symbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357Symbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081EY56
-
PfizerBörse Börse MünchenISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22Symbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52Symbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081DH33
-
PfizerBörse BUEISIN US717081EV18
-
ISIN US717081EX73Symbol PFE
-
PfizerBörse OMXSISIN US7170811035
-
ISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
1.790 News & Informationen zur Pfizer Aktie
Now that a COVID-19 shot is fully approved, employer mandates are rolling in. But will vaccination rates in the U.S. go up?
The long-awaited (and for some, much-debated) approval of BioNTech and Pfizer’s COVID-19 is here, and the employer mandates are already rolling in.
3 COVID Vaccine Makers to Watch on Pfizer Jab Full FDA Approval
Stocks of coronavirus vaccine makers BNTX and MRNA fly high following complete approval of Pfizer's COVID-19 vaccine. The momentum is likely to continue for these stocks. JNJ is another strong contender in this field.
Global Immunology Market to Surpass US$ 156,378.2 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, Aug. 24, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global Immunology market is estimated to be valued at US$ 91,850…
Crude Oil Higher; Mexican Fire Hits Output By Investing.com
Crude Oil Higher; Mexican Fire Hits Output
Morning Update: Catholic Church charity set up to pay survivors of residential schools spent $6.46-million on expenses, records show
Plus, new dangers await Afghan evacuees making their way on foot to Turkey, while those hoping to get on Canadian flights say they aren’t getting sufficient information from officials
Bulls push Sensex, Nifty higher for second day straight; here’s what experts make of today’s trade
S&P BSE Sensex ended the day 403 points or 0.73% higher at 55,958 points while the NSE Nifty zoomed 0.78% to close at 16,624.
KLCI closes at two-month high after third straight day of gains
The FBM KLCI marched higher for the third straight trading session to close at its two-month high, as investors collected oversold stocks following the recent selldown.
Coronavirus tally: Daily average for new cases, deaths and hospitalizations keep climbing to multi-month highs
The global tally for the coronavirus-borne illness climbed to above 212.61 million as of early Tuesday, while death toll rose to 4,442,545, according to data…
BioNTech : Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older (Form 6-K)
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
… | August 24, 2021
A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings
Pre-open movers
U.S. stock futures traded higher in early pre-market trade after the Dow Jones and Nasdaq surged more than 200 points each in the previous …
North American Morning Briefing: Tech Gains -2-
Scott Ruesterholz, portfolio manager at Insight Investment, said speculation about tapering may cause intermittent spikes in bond yields. However, the asset manager remains opportunistic because…
Stocks Extend Rebound, Dollar Tanks As Fed Taper And Delta Worries Ease
Market Overview Analysis by XM Group (Trading Point) covering: NZD/USD, Pfizer Inc, Copper Futures, NASDAQ Composite. Read XM Group (Trading Point)'s latest article on Investing.com
Top 5 High-Yielding Stock Market Gainers YTD With More Upside
Stocks Analysis by Zacks Investment Research covering: ConocoPhillips, MetLife Inc, Pfizer Inc, American International Group Inc. Read Zacks Investment Research's latest article on Investing.com
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
Japanese shares end higher as tech tracks Wall Street's gain
Wall Street's main indexes ended higher on Monday, with the Nasdaq closing at an all-time high, after the US Food and Drug Administration (FDA) granted full approval to the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE .
European Stocks Higher; Marks & Spencer Soars with U.K. Retail Sector in Play By Investing.com
European Stocks Higher; Marks & Spencer Soars with U.K. Retail Sector in Play
Commodity strategies: Gold, silver, crude, base metals
Here is a look at how different commodities are behaving in todays market
Hawaii governor urges visitors to stay away amid COVID surge By Reuters
Hawaii governor urges visitors to stay away amid COVID surge
Trillium Therapeutics Aktie – Starkes Kursplus dank Pfizer-Übernahme
Trillium Therapeutics Aktie steigt um 184,51 %, nachdem bekannt wurde, dass Pfizer das Unternehmen kauft. Lohnt sich noch ein Einstieg?
Oil rises as full U.S. clearance for COVID-19 vaccine stokes demand hopes
SINGAPORE — Oil prices rose on Tuesday after the U.S. drug regulator granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, stoking investor…
Dollar Stabilizes After Sharp Drop; Jackson Hole Meeting in Focus By Investing.com
Dollar Stabilizes After Sharp Drop; Jackson Hole Meeting in Focus
European Stock Futures Edge Higher; German GDP Rebounds By Investing.com
European Stock Futures Edge Higher; German GDP Rebounds
PureTech Health plc : – Half-Year Report
Strong capital base and cash runway expected into the first quarter of 2025, with PureTech level cash and cash equivalents of $409.7 million1 and consolidated cash and cash equivalents of $439.8… | August 24, 2021
Pfizer to acquire cancer drugmaker Trillium for $2.3 billion
It invested $25 million in Trillium in September as part of its ‘Breakthrough Growth Initiative’
ETMarkets Morning Podcast: Is this the beginning of the end of broader market rally?
Tune in as we tell you what's happening in the market, what's making news this morning, and look at some of the buzzing stocks.
Oil Up, Fuel Demand Outlook Clears Over Full Vaccine Approval By Investing.com
Oil Up, Fuel Demand Outlook Clears Over Full Vaccine Approval
ASX Update: Oil, tech shine in second day of gains
Crude oil rises on fuel demand hopes
Brent crude oil futures gained 66 cents, or 0.9 per cent, to $69.41 a barrel
Oil rises as full US clearance for Covid-19 vaccine stokes fuel demand hopes
Brent crude oil futures gained 66 cents, or 0.9%, to $69.41 a barrel by 0201 GMT, while US West Texas Intermediate (WTI) crude futures increased by 60 cents, or 0.9%, to $66.24 a barrel.
Japanese shares track Wall St higher; SoftBank, chip shares gain
TOKYO — Japanese shares rose on Tuesday, tracking Wall Street’s strong finish overnight, as heavyweights SoftBank Group and chip-related stocks jumped along…
Asian stocks rally on extended Wall St bounce, easing Fed taper worries By Reuters
Asian stocks rally on extended Wall St bounce, easing Fed taper worries
Share Market Live: SGX Nifty Hints At Gains; Aptus Value, Chemplast Sanmar To List Today
Catch all live updates on share prices, index moves, corporate announcements and more from Indian stock markets today.
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes By Reuters
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes
SINGAPORE — Oil prices rose on Tuesday after the U.S. drug regulator granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, stoking investor…